
On Thursday, Zealand Pharma publicized its annual report for 2021, showcasing lower sales and greater costs compared to the preceding year.
The company had a 2021 revenue of USD 44.6m, which is down from 2020’s USD 54.2m.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app